Sort
50,496 grants matching “lung cancer”
Hermansky Pudlak Syndrome & melanosome formation
$503,535Michael S Marks · University Of Pennsylvania · R01 · FY2011 · EY
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival
$503,520Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer
$503,508Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2023 · CA
Novel approach to attenuate small cell lung cancer growth and metastasis
$503,488Mohd Wasim Nasser · University Of Nebraska Medical Center · R01 · FY2019 · CA
Understanding the induction of T cell dysfunction in the context of lung cancer
$503,480Stefani Spranger · Massachusetts Institute Of Technology · R37 · FY2024 · CA
Computational Approaches for RNA StructureFunction Determination
$503,448Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Benzo[a]pyrene Micro-dosing of Humans: A New Tool for Exposure, Risk Assessment and Prevention
$503,436David E. Williams · Oregon State University · R01 · FY2020 · ES
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling
$503,421Michelle Christine Mendoza · University Of Utah · R01 · FY2023 · CA
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
$503,415Sourav Bandyopadhyay · University Of California, San Francisco · R01 · FY2021 · CA
ALPHA 1 AD CARRIERS AND LUNG CANCER RISK
$503,405Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2000 · CA
Project 1 Mouse Models Analysis
$503,335Edgar G. Engleman · Stanford University · U54 · FY2024 · CA
Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation
$503,327Laurie G Hudson · University Of New Mexico Health Scis Ctr · R01 · FY2023 · ES
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
$503,309Alexander Sparreboom · Ohio State University · R01 · FY2017 · CA
Protein Kinase Signaling and Cell Cycle Control
$503,262Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2015 · ES
Protein Kinase Signaling and Cell Cycle Control
$503,262Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2016 · ES
Protein Kinase Signaling and Cell Cycle Control
$503,262Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2013 · ES
Protein Kinase Signaling and Cell Cycle Control
$503,262Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2017 · ES
Advanced C-arm imaging platform for histotripsy treatment of liver tumors
$503,242Paul F Laeseke · University Of Wisconsin-Madison · R01 · FY2025 · EB
Systematic Error and Confounding: Meta-Analyses of Alcohol and Disease
$503,203Kaye M Fillmore · Scientific Analysis Corporation · R01 · FY2011 · AA
Assessing the efficacy of a ROR1:PD-L1:CD2 multispecific T cell engager in ROR1-positive and -negative neuroblastoma models
$503,194James M Olson · Seattle Children'S Hospital · R21 · FY2024 · CA
Transdisciplinary Cancer Control Research Training Grant
$503,181William Rakowski · Miriam Hospital · R25 · FY2009 · CA
Objective decision support environment for clinical trials
$503,175Bradley J. Erickson · Mayo Clinic Rochester · U01 · FY2014 · CA
The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease.
$503,160Leah J Siskind · University Of Louisville · R01 · FY2023 · DK
The Impact of Tobacco Control Policies on Health Equity in the United States
$503,153Nancy Fleischer · University Of Michigan At Ann Arbor · R37 · FY2019 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$502,945Elizabeth Mittendorf · Methodist Hospital Research Institute · U54 · FY2016 · CA